ARCHIVES OF

THE BALKAN MEDICAL UNION

The official journal of the Balkan Medical Union, since 1935

Citation Abbreviation:

Arch Balk Med Union

Conditioned medium of mesenchymal stem cells: dual anti-inflammatory and analgesic effects in rheumatoid arthritis model

0

Background. Rheumatoid arthritis (RA) is a common autoimmune disease. Current therapies, including anti-inflammatory drugs, corticosteroids, disease-modifying antirheumatic drugs and biologic agents, have limitations such as adverse effects and loss of efficacy. The conditioned medium of mesenchymal stem cells (CM-MSC) may offer an alternative due to its regenerative and immunomodulatory properties.
The objective of the study was to characterize the anti-inflammatory and analgesic activity of the CM-MSC in an adjuvant arthritis (АА) model in rats.
Materials and methods. CM-MSC was obtained by culturing umbilical mesenchymal stem cells (MSCs) in serum-free medium, filtering, and standardizing for galectin-1 content (6.0 pg/mL). It was administered intramuscularly to rats at a dose of 0.6 ml/kg body weight. AA was induced by injecting complete Freund’s adjuvant into the right hind limb. Treatments were given from day 14 to 28 post-induction. The anti-inflammatory activity was measured by changes in limb volume, while analgesic activity was assessed via mechanical compression. Rats were divided into four groups: control, diclofenac sodium, CM-MSC, and saline.
Results. CM-MSC reduced paw edema by 22.0% (p = 0.01) and increased the pain threshold by 42.7% (p < 0.01) in a rat model of AA. Diclofenac sodium produced more pronounced effects; however, CM-MSC still demonstrated statistically significant anti-inflammatory and analgesic activity.
Conclusions. These findings suggest that CM-MSC holds promise as a cell-free therapeutic approach for managing chronic inflammation and pain in rheumatoid arthritis. Further studies are needed to elucidate the underlying mechanisms and optimize treatment protocols.
Keywords: mesenchymal stem cells, rheumatoid arthritis, adjuvant arthritis, autoimmune diseases, stem cell therapy.

Address for correspondence:
Fedir HLADKYKH
Department of Infectious Diseases and Clinical Immunology, School of Medicine, V. N. Karazin Kharkiv National University
Address: 4, Svobody Sq, Kharkiv 61022, Ukraine
Е-mail: fedir.hladkykh@gmail.com; Phone: +38099782787

Share.

Comments are closed.

Hladkykh F, Student V, Liadova T, Lykhatska H, Komorovsky R, Smiyan S. Conditioned medium of mesenchymal stem cells: dual anti-inflammatory and analgesic effects in rheumatoid arthritis model. Arch Balk Med Union. 2025;60(4):483-491. https://doi.org/10.31688/ABMU.2025.60.4.04